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Abstract 
A high pressure liquid chromatography method was established to analyse 
carotenoids in specimens from human and rats. The method utilises an isocratic elution 
of specimens from a silica column, using 16% dioxane in hexane. 
The selected method demonstrated that the major carotenoid in human serum is 
B-carotene, while lutein is the major carotenoid in subretinal fluid. The results are 
consistent with the current knowledge on the occurrence of B-carotene in human serum 
and lutein in the retina. 
On the other hand, the selected method showed negligible carotenoid in serum, 
liver and retina of rats. The absence of carotenoids in rat serum and retina accounts for 
part of the reason for the high sensitivity of rat's retina to photic injury. 
Although feeding lutein or astaxanthin did show the appearance of the respective 
carotenoid in some specimen of the blood or tissue, the concentration was in the lower 
limit of our analytical method. This concentration was <1% of the values observed in 
human serum. Others have demonstrated the protective effect of lutein and astaxanthin 
against photic injury to rat's retina. These results indicate that the high potency of 
carotenoids because only a trace amount of them is needed to protect the retina from 
photic injury. Alternatively, the excessive amount of orally administered carotenoids 
might preserve the efficiency of other endogenous antioxidants in the retina. 
xiii 
I. INTRODUCTION 
A. Current knowledge on carotenoids: 
1. Chemistry of carotenoids: Carotenoid was isolated from carrot in 1831. The 
structure was not clearly elucidated until 1925. Chromatographic technique was used to 
isolate and identify these pigments (Fruton & Simmonds, 1958). 
Carotenoids are consisted of a long hydrocarbon backbone with a series of 
conjugated double bonds. The basic structure is made up of eight isoprene units. Each 
isoprene molecule has five carbon atoms as shown below. The main stem is formed by 
joining the two ends of the isoprene after the shifting of the double bond to the centre 
(Weedon & Moss, 1995). 
Although the number of carbon in 
the chain may vary slightly, the C40 CH^ 
CH2=C-CH=CH2 
backbone is considered as the main stem 
of the structure in carotenoids (Britton, isoprene 
1995). Lycopene and P-carotene are two 
typical examples of carotenoids with C40 backbone. The addition of one or more 
isoprene units leads to the formation of larger carotenoids such as decaprenoxanthin or 
sarcinaxanthin (Ferezou, 1992; Weedon & Moss, 1995). In some cases when C40 
carotenoids are shortened by degradation, they are called apocarotenoids such as 
capsorbin and capsanthin. Other chemical reactions such as hydrogenation, 
dehydrogenation, cyclization and oxidation will modify the basic structure of 
1 
carotenoids (Pfander, 1992; Britton, 1995). These chemical processes enable the 
diversification of these natural pigments. 
The hydrocarbon-containing carotenoid is called carotene such as lycopene, p_ 
carotene and torulene. Carotenoids containing one or more oxygen group are known as 
xanthophylls Q^ussbaum et al, 1981; Armstrong, 1996). Xanthophyll includes a major 
series of carotenoids. Lutein, astaxanthin and canthaxanthin are some widespread 
xanthophylls found in the world (Latscha, 1990). Some of their structures are shown in 
the following. 
F|/^ w/k^ %^^ X^ =^%>^ =V^ ^^ w<^ V^ /"%>^ j ^^P<j/^^^^^^^ =^^"/^=^/L>^ %^^^^ :^Y^^^/^^^^^^^_/^=>^ J^J^  
^ ^ lycopene Hd^_A^ zeaxanthin 
j><j^ ^^ =^^ /"^ >^^ ^^ ^^ ^^ ^^ =^ ^^ "^^ >^ "^"^ Y^ =^ ^^ ^^ "i^ "H>^ ^^  j><^ /^^ %>^ k^^ /%^ L^^ ^^ ^^ /^ =%^ >>^ ^^ -^/^ ^^ Y"H"-^ x^^  
^ ^ beta-carotene HckA^ lutein 
0 
i^ j^^^^w^^^>^^^/^=^ "^^ w^^^^%^>^ Y^"^ =^""^ "^^Y^^^""""^^^^^^^  ^^^^ j^^^^%~/^k^^^H~/k^-^"^=%>^/^ ~^^/"^ %^^x^=»Y^ H^s^^^^^^^^^  
cryptoxanthin & ^ astaxanthin 
Besides the variation of different functional groups present in various 
carotenoids, these pigmented molecules exist in a great variety of isomer forms. The 
occurrences of geometric isomers of each double bond are possible (Britton, 1995). 
Normally, the trans isomer is the most stable configuration (Handelman, 1996). 
Due to the long, linear and conjugated carbon chain, carotenoids have a specific 
absorption characteristic in the visible spectrum. Most carotenoids have a typical 
absorption maximum (A^^) in the visible spectrum shown in figure lb to 3b. The triple 
peaks enable the spectrophotometric recognition of the carotenoids. The A^^ of a 
carotenoid is resulted from the transition of electron from the lowest vibrational level of 
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the electron at ground state to the lowest vibrational level of the excited state (Kohler, 
1995). 
The location, shape and intensity of the A^^ x depend on a number of factors: (a) 
solvent effect (b) length of the chromophore (c) presence of cyclic ring (d) geometric 
isomer and (e) functional groups. The higher the refractive index of the solvent, the 
greater the A^^ of the carotenoid. The length of the chromophore is determined by the 
number of conjugated double bonds (Englert et al, 1971; Kohler, 1995); the longer the 
polyene chain, the longer the wavelength in the absorption maximum. Cis isomer leads 
to a mild decreased absorbance and hypsochromic shift (displacement of A^^ to short 
wavelength) of the A^^. The most frequent form of cis-isomer exists in the double bond 
near the centre of the molecule (Britton, 1995). The fine structure will also affect the 
spectral properties. For example, addition of carbonyl group will cause bathochromic 
shift of the A^^ (displacement of A^^ to long wavelength) while the presence of 
epoxide group leads to an hypsochromic shift of the A^^ ^ (Englert et al, 1971). 
Although there is a predictable trend for the absorption characteristics of the 
spectrum, it is impossible to identify the detail structure of a carotenoid by the 
absorption spectrum alone. 
The chemical structures of commonly occurring carotenoids have been 
thoroughly studied. Because of the improvement of chromatographic techniques, new 
carotenoids are being discovered continuously. 
2. Occurrence of carotenoids: Carotenoids are the most diversified natural 
pigments found in the animal and plant kingdoms (Latscha, 1990; Goodwin, 1992). 
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These pigments enrich the colour of the world. More than 600 types of carotenoids are 
distributed among the plant and animal kingdom (Straub, 1987). Most carotenoids are 
synthesised by green plants and green algae. Some of them are synthesised by bacteria 
or yeast. However, animals cannot synthesize carotenoids. 
(a) Micro-organisms: Carotenoids are found in both photosynthetic and non-
photosynthetic bacteria. The purple and green bacteria are another subtypes of 
photosynthetic bacteria. Their carotenoids are located in the chromatophores of the cell 
membrane. In non-photosynthetic bacteria such as archebacteria (e.g. Halobacterium) 
and enbacteria, the carotenoids have a carbon chain of C30, C45 or C50 rather than the 
usual C40 carotenoids found in plants and animals. The carotenoids are deposited in the 
cytoplasmic membrane. 
(b) Plants: Higher plants have highly extensive and tissue-specific carotenoids. 
The pigments are located in two essential positions with respect to its functions. The 
first one is chloroplast in which photosynthesis takes place. When the chloroplast 
disintegrates, carotenoids are released into the cytoplasm and then the photosynthetic 
tissue changes to yellow. That is the major colour of the withered leaves in autumn 
(Latscha, 1990). The second location for the accumulation of carotenoids is the 
reproductive organ such as fruit, pollen or petals in chromoplast. Some reproductive 
organs of higher plants do not have carotenoids. They are species specific. The 
variations of colour in fruit and flowers' petals are caused by the presence of unique 
carotenoids. 
In lower plants, such as algae, the chloroplasts are the major source of 
carotenoids. Their synthetic pathway resembles that ofhigher plants. The carotenoids of 
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both higher and lower plants are attached to the protein of the chloroplast membrane. 
During reproduction, carotenoids may be stored outside the chloroplast in lipid 
vacuoles. Microalgae such as Haematococcus is a very common algae found in nature. 
It accumulates P-carotene, lutein and astaxanthin ester in the cytoplasm. 
(c) Animals: They cannot make their carotenoids. Carotenoids are derived from 
the diet. On the other hand, carotenoids are not absorbed by all animals. The 
occurrences of carotenoids in animals are species specific as well as tissue specific 
(Latscha, 1990). 
Astaxanthin is widely distributed in marine animals such as sponges, crustaceans 
or fish. Beside astaxanthin, fish also contain lutein and zeaxanthin. Birds accumulate 
lutein, astaxanthin and canthaxanthin in their feathers, legs, feet or comb (Hudon et 
al,1992). Within the animal kingdom, carotenoids are relatively low in mammals. B-
carotene accumulated by cattle, horse and wapiti but not in sheep, pigs or cat (Latscha, 
1990). Primate is one of the mammals that could store a considerable amount of 
carotene and xanthophyll. 
(d) Human retina: The presence of non-bleaching yellow pigment in the human 
retina has been noted since 1782 ^sfassumm et al 1981). These macular pigments are 
distributed in the outer and inner plexiform layers in human and monkey (Snodderly et 
al 1979; 1984; 1995). 
Lutein is the major pigment in the retina OSfassumm et al 1981). Several studies 
(Bone et al, 1985; Handelman, 1988) described the presence of two oxygenated 
carotenoids, lutein and zeaxanthin, in human retina using chromatographic and mass 
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spectrometric method. Similar results were found in monkeys (Handelman，1991; 
Snodderly，1991). Zeaxanthin is concentrated at the macular region while lutein is 
dominant in the peripheral region of the retina. 
(e) Serum: Although mammals are relatively poor in accumulating carotenoids 
(Latscha, 1990; Krinsky et al, 1990), some reports (Kelly et al, 1950; High et al, 1951; 
Shapiro et al 1984) describe that rodent tissues contain carotenoids only after long term 
administration with a high dosage. Shapiro et al (1984) studied the uptake of P-carotene 
in Sprague-Dawley rats. The dosage of 150 mgy1cg was used for 21 weeks in order to 
record an obvious level of p-carotene in serum and other tissues. 
On the other hand, the concentration of carotenoids in the primate is obviously 
higher than that in the rodent (Krinsky, 1990; Snodderly, 1990). The variations of 
carotenoids in monkey and human were large. In human, the standard deviation could 
be half to two third of the mean value (Carughi, 1993; Mares-Perlman et al, 1995; 
Kostic et al 1995). It indicates that the mechanism of uptake is multifactorial. 
3. Metabolism of carotenoids: Most of previous metabolic studies are 
concentrated on P-carotene. The metabolism of carotenoids involved the degradation 
and structural modification of the molecules. That involves the catabolic breakdown to 
apocarotenoid, epoxycarotenoids or retinoids. The oxidation of the immediate products 
can eventually degrade to CO2 and H2O. In animals, p>carotene is the most widely 
studied carotenoid in the metabolic process. Pro-vitamin A activities received the 
greatest attention. 
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In plants, ripening of fruit is an example of carotenoid metabolism. During 
ripening, chlorophyll and carotenoids are released from the chloroplast into the 
cytoplasm. Carotenes are degraded to apocarotenoids and further oxidized to terpenoid 
products or even CO2 and H2O. On the other hand, xanthophyll are esterified with fatty 
acids and persist in the cytoplasm. In the fruit of paprika, zeaxanthin is converted to 
capsanthin and capsorubin. The whole process involves the change from green to yellow 
and finally to a red colour product. 
In animals, Oslon (1993, 1994) demonstrated the cleavage of P-carotene at the 
centre of the molecule. The formation of retinal from P-carotene was found in both the 
liver and intestine homogenate of rats. Other carotenoids such as astaxanthin, 
canthaxanthin also have pro-vitamin A activities (Latscha, 1990; Schiedt, 1985). Retinol 
is esterified with fatty acid in the human intestine and is transported to the liver by 
chylomicrons (Erdman et al, 1993; Parker, 1995). 
Other catabolic products such as p-apo-8'-carotenal, P-apo-13 ‘-carotenal were 
found in the ferret or human intestine homogenate. All these studies indicate central and 
random cleavage of the provitamin A carotenoids or P-carotene in the metabolic 
pathway (Olson, 1993; Parker, 1995). 
Krinsky (1993) demonstrated the in vitro conversion of p-carotene to retinyl 
ester in rats and monkeys. He suggested the species variation in provitamin A activities. 
In vivo study in human, rats and ferrets confirmed that the dietary supplement of P-
carotene resulted in retinyl ester and unmetabolised P-carotene (Weiser et al, 1993; 
Vliet et al, 1995; Rock et al, 1996). 
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4. Biological function: The most well-known function of the pigments is the 
colour signal produced for communication and species recognition of both animals and 
plants. The colour and pattem of carotenoids could be expressed as attraction, protection 
or warning signal (Latscha, 1990). 
In plants, the biological functions are studied in more detail comparing to that of 
animals (Davies, 1985). Carotenoids can absorb light and transfer the excited energy to 
the chlorophyll for photosynthesis (Olson, 1992; Schalch, 1992; Krinsky, 1994;). They 
protect plant tissues against photoxidation when the chlorophyll is excited to its triplet 
state. Similarly, carotenoids quenched the energy in a singlet oxygen during the 
photochemical process. These pigments can work as light energy conductor due to the 
7i-elections in the conjugated double bond (Latscha, 1990). 
The function of carotenoids in animals is based on the study with P-carotene. In 
animals, pro-vitamin A activity is the well-known function (Krinsky, 1993). The series 
of conjugate double bonds enable carotenoids to function as an antioxidant (Liebler, 
1993; Olson, 1994; Sies, 1995). Carotenoids may work by its own action or preserve 
other antioxidants in the biological system. In vitro studies have been used to quantify 
the bleaching effect or oxidation products after the addition of carotenoid (Burton, 
1984; Miki, 1991; Chopra et al, 1993). Animals study using rats, chicken and guinea 
pigs demonstrated the decrease in lipid peroxidation after taking p-carotene, astaxanthin 
orcanthaxanthin (Palozza, 1992). 
Some carotenoids such as p-carotene and canthaxanthin affect the gene 
expression ofthe protein connexin 43. This protein can promote the communication of 
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adjacent cells via the gap junction (Bendich，1993). Other possible actions of the 
carotenoids are: (1) Maintenance of the normal reproduction process in bird, cattle, 
horse and pig, (2) Fertilization and growth in fish and crustacean (Latscha, 1990). 
The role of carotenoids in the retina is not fully understood (Berman, 1991; 
Gerster, 1991). Several epidemiological studies (Goldberg et al, 1988; Seddon et al, 
1994; Richer et al, 1996) reported that carotenoids were deficient in eye diseases such as 
age-related macular degeneration and cataract. However, Mares-Perlman et al (1995) 
did not find any strong association between carotenoids level in the blood and the 
incidence of age-related macular degeneration. 
Since the pigments distributed in the inner and outer plexiform layer of the 
neuroretina, they were believed to screen out blue light with its absorption effect 
QS[assbaum et al, 1981; Marshall, 1985; Schalch, 1992). Monkeys taking carotenoids 
deprived diet demonstrated changes in the integrity of retina (Malinow et al, 1980). 
Relationship between age-related macular degeneration and macular pigment had been 
proposed (Goldberg et al, 1988; Snodderly, 1995). The actual mechanism had not been 
elucidated yet. 
Protective effect of carotenoids against light injury to rat retina has been 
demonstrated by Tso (1989) and Lam (1996). Photic injury is related to free radical 
formation during exposure to light. The exact mechanism is not yet known. 
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B. Statement ofproblem 
As reviewed above, others have postulated a role of carotenoids as an effective 
antioxidant. Among different kinds of carotenoids, astaxanthin has the highest 
antioxidant activity tested in vitro. However, it is not certain if astaxanthin has the same 
potency in vivo as effective as the results indicated in the in vitro experiments. On the 
other hand, lutein is the major carotenoid in human retina. Therefore, astaxanthin and 
lutein are selected for the present study. 
Rat is a convenient animal model to study photic injury to the retina. Light-
induced free radical damage to rat's retina has been studied thoroughly in the past. 
However, the absorption and metabolism of lutein and astaxanthin by rats are not 
known. In order to use rats as an animal model to assay for the biological potency of 
carotenoids against photic injury, it is important to know the ability of rats to utilise 
carotenoids in the diet. 
This study began with the selection of a chromatographic method for the 
analysis of carotenoids. The selected method was used to analyse carotenoids in human 
serum and subretinal fluid to assure that the selected method produces data comparable 
to the current knowledge of carotenoids. The selected method was used to study 
carotenoids in rats' liver, serum and retina in order to assess the value of rat as an 
animal model to study the potency of carotenoids against photic injury. 
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II. MATERIAL AND METHODS 
A. Material 
1. Animals: Eighty four male Lewis rats were used in the carotenoids feeding 
experiment. They were supplied by the Animals House of the Chinese University of 
Hong Kong. The age of the animals was 40 to 50 days old. The animals were kept in 
cages with three to four animals in each cage. A normal carotenoid-free diet (Prolab 
RMH 2500, PMI Feeds Inc., St. Louis, MO) was given every day. All animals were 
kept in 12 hours cyclic light for at least 1 weeks before the feeding of carotenoids. The 
dark cycle sustained at an average of 0.1 to 0.6 foot-candle while 46 to 55 foot-candle in 
the light cycle. The temperature was maintained between 20 and 23° C. The relative 
humidity of the animal room was kept between 48 to 60 %. 
2. Human samples: 
(a) Serum: Thirteen samples ofhuman serum were collected from TODAY X-
Ray & Medical Laboratory Company Limited in Kwun Tong. The blood was drawn for 
a routine medical examination. The patients had no known disease. The samples were 
extracted with ethanol and hexane for three times. The extracts were combined, 
redissolved in 50 ^1 of dioxane in hexane (VAV: 16/84). 40 [xl was used for HPLC 
analysis. 
(b) Subretinal fluid: Six patients with rhegmatogenous retinal detachment 
were studied. They are patients in Tung Wah East Hospital. Three patients had acute 
superior bullous detachment, two patients had chronic inferior retinal detachment, one 
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had total retinal detachment with grade C proliferative vitreoretinopathy. The patients 
were treated by scleral buckling, cryopexy and drainage of subretinal fluid. An aliquot 
of 150 to 250 ^1 of subretinal fluid was obtained during the operation. Blood samples of 
the above patients were also collected at the time of surgery. 
3. Chemicals: 
(a) Standards for HPLC: All trans-retinol acetate, retinal, retinoic acid, retinol, 
B-carotene and ascorbic acid were supplied by Sigma Chemical Company, St. Louis, 
MO; lutein, zeaxanthin, cryptoxanthin by IndofIne Chemical Company, Belle Mead, 
NJ; lycopene, by Markhteshim Chemical Works, Ltd. Beer-Sheva, Israel. 
(b) Carotenoids supplement: Carophyll Pink (F. Hoffmann-La Roche Ltd. 
AG-4002 Basel, Switzerland) was one kind of granulated beadlets in which the 
synthetic astaxanthin was distributed in a starch-encapsulated gelatine and carbohydrate 
matrix. The diameter of the beadlets varied from 0.15 to 0.4 mm(Latscha, 1990). 
Yellow Pixafil (Industrias Alcosa, S. A. de C.V.) is a source of lutein derived 
from marigold petals in powder form and was used as a supplement for poultry diet. The 
pigment was kept at 4°C in opaque aluminium bags. 
4. High Pressure Liquid Chromatography apparatus 
(a) HPLC apparatus: Waters 600 LC system, Waters 996 photodiode array 
detector were used in all HPLC analysis. 
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(b) Columns: Nova PAK silica columns (3.9x300 mm, 3.9x150 mm) were 
supplied by Waters Associate. 
(c) Solvent: Hexane and ethanol was supplied by Riedeel-de Haeen, Germany; 
Dioxane (1-4-Dioxan Chromasolv), by Fluka Chemical, Buch; lOmM ammonia 
phosphate by Sigma Chemical Company, St. Louis, MO. 
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B. Methods 
1. Animal specimens 
(a) Carotenoid supplement: Carophyll Pink (F. Hoffmann-La Roche Ltd. AG-
4002 Basel, Switzerland) was grounded in a porcelain mortar for 5 minutes. The sample 
was suspended in olive oil (Bertolli Inc., milano, Italy) to a final concentration of 
lmg/ml or 10 mg/ml astaxanthin. Yellow Pixafil (Industrias Alcosa, S. A. de C.V.) was 
suspended in olive oil (Bertolli Inc., milano, Italy) to a final concentration of 1 mg/ml, 
10 mg/ml or 30mg/ml. One ml of carotenoid containing oil was fed to rats. The sample 
was fed to each rat through a stomach tube, once a day for 6 days. Two kind of control 
animals were used. A control group was kept under normal diet (n=10). The second 
group of control rats (n=34) were fed in the same manner as the treated group with olive 
oil. 
(b) Tissue preparation: The rats were euthanized 16 hours after the last feeding 
of carotenoids. Deep anaesthesia was maintained by intraperitoneal injection of 
nembutal (40 mg/kg bodyweight). The animals were dissected just below the thoracic 
cavity and 5 to 8 ml of venous blood was obtained by heart puncture at the right auricle. 
The rats were perfused with about 150 ml of saline and perfusion was ensured by the 
whitening of the fundus. 
Retina: The eyes were enucleated. The globe was dissected at the limbus. The 
lens was removed, and the retina was removed by a pair of forceps. The attachment to 
the optic nerve was cut by a pair of scissors. The tissue was weighed and stored at -
84�C. 
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Serum: The blood samples were allowed to coagulate at room temperature for 15 
to 20 minutes. Serum was separated from the blood cells by centrifugation at 7000xg for 
10 minutes. The samples were stored at -84°C before carotenoid analysis. 
Liver: The lower end in the right lobe of the liver was excised after perfusion. 
The samples were kept at -84°C for later analysis. 
2. Human specimens: About 5 ml of venous blood was collected from each 
patient at the time of retinal detachment surgery. After coagulation, the samples were 
subjected to centrifugation at 7000xg for 10 minutes. The serum was kept at - 8 0 � C for 
later analysis. 
Subretinal fluids were collected during surgical repair of the detached retina. 
The area around the drainage site was cleared of irrigation fluid and blood. The sclera 
was punctured by a 27 Gauge needle passed perpendicularly to the sclera where the 
retinal detachment was the most bullous and major choroidal vessels were avoided. The 
needle was advanced for about 0.6 to 0.8 mm deep to enter into the subretinal space. 
The globe was gently massaged to facilitate drainage of the subretinal fluid via the 
needle to a tuberculin syringe. The specimen was then centrifuged for 10 minutes at 
7000 xg to remove the cellular components. 
3. Extraction of lipid component 
(a) Retina: Each sample was mixed with 200 |il deionized water and sonicated 
for 2 minutes. An equal volume of acetone was added to coagulate the proteins. The 
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sample was mixed with 800 i^l hexane by vertex. After sonication and centrifugation, 
the upper supernatant was removed and evaporated to dryness in the lyophilizer. The 
hexane extraction was repeated twice and the lipid extract was combined and evaporated 
to dryness. The lipid residue was re-dissolved in 16% dioxane in hexane for HPLC 
analysis. 
(b) serum or subretinal fluid: An aliquot of 0.2 ml of sample was mixed with an 
equal amount of absolute ethanol. Lipids in the samples were extracted by mixing 
vigorously with 0.8 ml of hexane for 3 min. The organic phase was separated from the 
aqueous phase by centrifugation at 2000 xg for 10 min. The aqueous phase was 
extracted in the same manner for two more times. The supernatant fractions were 
combined and evaporated to dryness in a Maxi Dry Lyo (Heto Lab. Equipment, Allerol, 
Demark). The residue was re-dissolved in 25 i^l of dioxane-hexane (16:84) immediately 
before chromatographic analysis. 
(c) liver: The liver tissue was cut into small pieces by a surgical blaze. About 
10 to 20 mg sample was weighed and homogenized in 0.2 ml of deionized water by 
sonication in a Branson Sonifer-450 for 6 minutes. The homogenate was mixed with an 
equal amount of acetone and vortexed for two minutes followed by the addition of 0.8 
ml hexane. The mixture was further sonicated and vortexed for 1 and 2 minutes 
respectively. The supernatant of the hexane extraction was removed after centrifugation 
at 5000 X g for 5 minutes. Hexane extraction was repeated twice and the extracts were 
recombined and evaporated to dryness in the lyophilizer. 
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4. Analytical methods 
(a) Isocratic elution: A Nova-Pak silica column (3.9 x 300 mm) was 
equilibrated with 16 % dioxane in hexane and eluted at 2 ml/min. Pressure was 
maintained around 1220 to 1340 psi under silk on condition. The dried organic extract 
of each sample was then redissolved in 50 |il elution solvent and 40 fil of the sample 
was injected into the column. The eluant was monitored for 15 minutes after injection. 
The chromatogram was analysed at 450 and 327 nm. 
(b) Gradient elution: The lipid extract was dissolved in 100 ^1 hexane and 50 i^l 
was injected into the column. The samples were eluted in the gradient mode from 0% to 
20 % dioxane within five minutes after sample injection. The concentration of dioxane 
was kept constant at 20 % dioxane after 5 minutes of gradient elution. The elution was 
monitored with a photo-diode array detector. The chromatogram was analysed at 450 
and 327 nm. 
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III. RESULTS 
A. Selection of chromatographic method for carotenoids analysis. 
1. Effect of dioxane concentration on the retention time (1^) of carotenoids: 
The separation of carotenoids on a silica column was examined by isocratic and by 
gradient elution. 
(a) Gradient elution (Table 1): Gradient elutions using 5-25%, 0-16% and 0-
20% dioxane in hexane were examined. When dioxane concentration was changed from 
5 to 25% in the first 5 minute, 6-carotene and lycopene were barely separated [T^ = 1.43 
士 0.01 (n=2) and 1.55 士 0.0058 (n=2)]. Lutein was eluted at 7.9 minute. When the 
gradient was changed to 0-16% dioxane in the first 5 minute, B-carotene and lycopene 
were separated by 1.2 minute. The T^  of lutein was delayed to 14.83 minute. When 
dioxane concentration was changed from 0 % to 20 % at the first five minutes, similar 
separation of B-carotene and lycopene was observed while lutein was recovered much 
earlier at 10.6 士 0.1 (n=4) minute. 
(b) Isocratic elution (Table 2): In our earlier studies, the 3.9x150 mm column 
was used. The concentrations of 15, 16, 25 and 30% of dioxane in hexane were used in 
isocratic elution. There was an inverse correlation between the T^  to the concentration of 
dioxane. The T^  of each carotenoid increased as the concentration of dioxane reduced. 
At a specified elution solvent, the order of carotenoid eluted from the column were P-
carotene, astaxanthin-1，lutein, zeaxanthin and astaxanthin-2. 
When the silica column was eluted by dioxane and hexane (25:75, VAO at 
lml/min. The T, of B-carotene, astaxanthin, lutein and zeaxanthin were 1.39 士 0.01 
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(n=10), 3.73 士 0.24 (n=9), 4.17 士 0.12 (n=7) and 4.54 (n=l) respectively. When the 
elution concentration of dioxane was changed from 25% to 30 %, the T^  of all 
carotenoids reduced. The changes in T^  of oxygenated carotenoids were much larger 
than carotenes. 
When the ratio of dioxane to hexane was changed to 15: 85, the T^  of B-carotene, 
lutein and zeaxanthin were delayed to 1.44 (n=l), 13.25 士 0.27 (n=4) and 14.16 士 0.081 
(n=2) respectively. Under the same condition, the cis and trans isomer of astaxanthin 
could be separated. The T^  of the trans isomer (astaxanthin-1) and the cis isomer 
(astaxanthin-2) were 10.02 士 0.02 and 12.97 minutes respectively (Table 2). 
In order to give a better separation for the carotenoids, a long silica column (3.9 
X 300mm) was evaluated. The samples were eluted from the column at a flow rate of 2 
ml/min. When p-carotene, lycopene, cryptoxanthin, astaxanthin-1, astaxanthin -2, 
lutein, zeaxanthin were eluted with 16% dioxane in hexane at 2ml/min. Their T, were 
1.35 士 0.02 (n=7), 1.38 (n=l), 3.32 士0.01 (n=2), 9.83 士 0.72 (n=2), 12.02 (n=l), 10.76 士 
0.17 (n=3) and 11.56 士 0.85 (n=5)minutes respectively. The T^  of astaxanthin and lutein 
eluted at 1 ml/min with 25% dioxane were shown in Table 3. 
2. Chromatograms of carotenoids and retinoids of a selected method for 
routine analysis: A long silica column (300 mm) eluted with 16 % dioxane in hexane 
was chosen for routine analysis. The pressure was between 1200 to 1300 psi at 
2ml/min. Carotenoids eluted from the column was detected by their absorbance at 450 
nm. Each peak in the 450 nm chromatogram was confirmed to be a carotenoid by its 
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characteristic absorption spectrum between 400 and 550 nm. For the study of retinoids, 
the eluant was analysed at 327 nm. The spectra of retinoids were examined between 300 
and 400 nm. The typical chromatograms and spectral analysis of carotenoids and 
retinoids are described in the following: 
(a) Carotenoids: Carotenoids have a unique absorption spectrum between 400-
550nm. The chromatograms of the carotenoids standard were shown in figures la to 6a. 
The shapes of the spectra were shown in figure lb-6b. The A^^ and T^  of these 
standards were shown in table 4. 
B-carotene has the typical triple-peak absorption spectrum in the visible region 
from 400 to 500 nm (figure lb). Besides the minor peaks below 360 nm, the spectrum 
of B-carotene (figure lb), cryptoxanthin (figure 3b), lutein (figure 5b) and zeaxanthin 
(figure 6b) are nearly the same. The A^^ ^ of each peak has a difference of 2 nm only 
(figure lb, 3b, 5b and 6b). The spectrum of lycopene has a much sharper absorption 
peak than other carotenoids. The main absorption bands have a bathochromic shift 
(figure 2b). The absorption spectrum of lutein is very similar to that of B-carotene 
except a mild spectral shift to short wavelength. It is also accompanied by a slight 
increase in crinkle of A^^ (figure 5b). Astaxanthin-1 has a single absorption peak at 475 
nm rather than three distinct peaks at the visible region (figure 4b). The spectrum is 
smooth with a small shoulder at 369 nm. The spectrum of astaxanthin-2, comparing 
with astaxanthin-1, has a 7 nm hypsochromic shift of the main absorption band. The 
presence of the absorption band at 369 nm denotes the cis-isomer of the astaxanthin 
(figure 4b)(Britton, 1995), 
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(b) Retinoids: Retinol and its metabolites are separable by the present HPLC 
method. The chromatogram was analysed at 320 nm to detect retinoids (figure 7a). Each 
retinoid has its characteristic A^^ . The absorption spectra of the retinoids were shown 
in figure 7b. 
The A^^ of each retinoid locates between 300 and 400 nm. Both retinol and 
retinol acetate have the absorption maximum at 327 nm and retinol has an additional 
A^^ at 230 nm. However, the T^  of retinol acetate is 1.58 minute while the T^  of retinol 
is 3.05 minute. The T^  for retinal and retinoic acid are 1.87 and 2.64 minutes 
respectively (figure 7a). The A^^ ^ of retinal is 370 nm while the A^^ of retinoic acid 
further shift to 350 nm. 
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B. Applications of the selected method to study carotenoid in human and rats. 
1. Study in human serum and subretinal fluid. 
(a) Serum: The concentrations of different carotenoids and retinol in the normal 
serum were displayed in table 5. At least 8 peaks were found in the 450 nm 
chromatogram of serum (figure 8a). All peaks had the typical A^^ ^ with the appearance 
of triple peaks of carotenoids between 400 and 500 nm (figure 8b, c). Only p-carotene, 
cryptoxanthin, lutein and zeaxanthin were recognised by their T^  and A^^ x (Table 4). 
Other carotenoids have not been identified yet. P-carotene had the highest concentration 
among the carotenoid found in the blood. Lutein was another major carotenoid. Only a 
trace amount of zeaxanthin was found in the blood and the concentration was too low to 
be documented by its absorption characteristics. 
When the serum was analysed at 327 nm, the major peak (peak 5) located at 3.1 
minute (figure 9a). The A^^ and T^  matched with that of retinol (Table 4). The A^^ of 
peak 1 to 4 indicated the presence of a mixture of unknown compounds. The possible 
occurrence of retinol ester, retinal and retinoic acid could not be identified by this 
method. The last peak has a spectrum of retinol and it is shown by heavy line (figure 
9b). 
(b) Subretinal fluid: When the subretinal fluid was analysed at 450nm, lutein was 
the major peak (figure lOa). The B-carotene peak (peak 1) was present, yet its 
concentration was < 3% of that in semm (table 6). A small amount of zeaxanthin was 
found in the subretinal fluid. The SRF/serum ratio for zeaxanthin and lutein were 
similar. The absorption spectrum of B-carotene (peak 1)，lutein and zeaxanthin peak 
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(peak 7，8) were shown by heavy lines in figure 9b. The spectrum was distorted by the 
base line noise due to the low concentration of carotenoids injected to the column. The 
result was sufficient to illustrate the absorption characteristic of B-carotene and lutein. 
The concentration of zeaxanthin was too low to be identified by the absorption 
spectrum. The other compounds eluted near the location of B-carotene had strong 
absorption at low wavelength UV light (<350nm). Yet negligible absorption in the 
visible light (450-550 nm) interfere with the absorption characteristic of carotenoids. 
The chromatogram of subretinal fluid recorded at 327 nm showed a group of 
peaks with low T^  (< 3 min) (figure l la) . The last peak (T[ = 3.05 min) was clearly 
separated from the others and had the typical absorption spectrum of retinol (figure 1 lb, 
heavy line). The earlier peaks overlapped each other. The chromatograms and spectra of 
the subretinal fluid at 450 and 327 nm (figure 10-lla,b) were qualitatively similar to 
that of semm (figure 8-9a,b). 
The average values of retinol, B-carotene, cryptoxanthin, lutein and zeaxanthin 
in serum and subretinal fluid are shown in table 6. The concentration of retinol in the 
subretinal fluid is 30% of that in the semm. The concentration of lutein in subretinal 
fluid is 38.7 ng/ml, equivalent to 26 % of that in serum. In spite of the high amount of 
retinol and lutein in subretinal fluid, the concentration of B-carotene and cryptoxanthin 
in subretinal fluid is very low (2.5 % and 2.8% of serum). The concentration of 
zeaxanthin in the subretinal fluid was much lower than that of p-carotene but the 
relative percentage was 22 % of that in the serum. There was no detectable lycopene in 
subretinal fluid. 
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2. Studies in rat's tissues 
(a) Liver: 
Normal diet (figurel2): Normal liver had 2 peaks (T^ at 3.8 and 4.4 minutes) 
in the 450 nm chromatogram (figure 12a). Peak 1 had an A^^ located at 205, 275 and 
327 nm. Peak 2 had A^^ ^ at 205 and 275 nm (figure 12b). Both peaks had strong UV 
absorption below 250 nm and they did not have the absorption spectrum of carotenoids 
even after they were highly magnified in figure 12c. 
Oil supplement (figure 13): When rats were fed with olive oil alone, five peaks 
were noted. The T^  were 1.95, 3.35, 4.19, 6.57 and 10.9 minutes respectively (figure 
13a). Peak 3 had the highest absorption among the five peaks. Peak 1 had an undefined 
spectrum with its A^^Sit 210 nm. It also had one shoulder at 280 nm (figure 13d). Peak 
2 had a very strong absorption at 327 nm. The spectrum of peak 3 had the A^^ ^ at 270 
nm and two minor peaks at 325 and 410 nm (figure 13b). Under high magnification, 
peak 1 and 4 had barely detectable absorption between 400 and 500 nm (figure 13d). 
These absorbances seemed to be carotenoids. 
Lutein, 1 mg/kg supplement (figure 14): The chromatogram of the liver tissue 
with lutein (1 mg/kg) (figure 14a) was very similar to the oil fed group (figure 13a). The 
absorbances of the small peak (peak 5) at the T, of lutein were approximately the same 
in both oil-supplement and lmg/kg groups. Peak 1 had the multiple peaks between 350 
and 400 nm while peak 3 possessed a board peak at 400 nm (figure 14c). According to 
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the spectrum ofeach peak, only barely detectable carotenoids could be observed in peak 
4 (figure 14d). 
Lutein, 30 mg/kg supplement (figure 15): As lutein dosage was increased to 
30 mgy^g，peak 4 and 5 in the liver were raised to the concentration that could be 
identified as the spectrum of carotenoids (Figure 15c). The T^  of peak 5 was identical to 
that of lutein (figure 15a) and this peak had the absorption spectrum of carotenoid 
(figure 15c). Peak 2 and 4a had the A^^ (327 nm) of retinol (figure 15b). None of the 
others had the A^^ of carotenoids. 
Astaxanthin, 1 mg>/kg supplement (figure 16): The chromatogram was similar 
to the one fed with lutein lmg/Tcg (figure 16a). After very high magnification of the 
spectra, only peak 4 had an appearance of carotenoids (figure 16c). 
Astaxanthin, 10 mg/kg supplement (figure 17): Five peaks could be observed 
when astaxanthin (10 mg/kg) was fed to the rats. T^  were 1.95, 3.35，4.2, 6.58 and 10.92 
minutes respectively (figure 17a). Peak 1 had three multiple A^ ^^ x located at 350, 369 
and 393 nm. The shape of the spectrum had the triple peak appearance of carotenoids in 
the visible spectrum (figure 17c) although the wavelength was shifted toward the UV 
side. Peak 2 had strong A^^ ^ at 327 run and the curve came down at 430 nm and 
flattened out onward. Peak 3 had strong absorption at 270 nm and deflections occurred 
at 323 and 400 nm. Peak 4 had strong absorption at 205 nm and flattened off to 300 
nm. (figure 17b，c). 
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Astaxanthin, 30 mg/kg supplement�figure 18): High dose astaxanthin raised 
the peak height of peak 1，2 and 4 in the 450 nm chromatogram (figure 18a). The 
spectrum of each peak was very similar to that of 10 mg/kg group (figure 17). Peak 4 
showed a barely detectable absorbance between 400 and 500 nm (figure 18c). T, ofPeak 
5 was corresponding to that of lutein. However, the spectrum was too weak to be 
identified as carotenoid. 
(b) Serum 
Normal diet (figure 19): When the animals were fed with normal diet alone, 
two peaks were noted with T^  of 1.44 and 1.73 minutes (figure 19a). Peak 1 had A^^^ at 
210, 270，325 nm (Figure 19b). Upon magnification, triple peak of carotenoid from 370 
to 480 nm could be seen in peak 1. Although the triple peak had visible colour, the A^^ 
shifted to the shorter wavelength (figure 19c). Peak 2 had strong absorption at low UV 
region and 295 nm. Little absorbance was observed at the visible wavelength. 
Oil supplement (figure 20): When olive oil was fed to the rats, 4 small peaks 
were observed in the 450 nm chromatogram of the serum (figure 20a). Their T^  were 
1.45, 1.72, 9.2 and 11.3 minutes respectively. Peak 1 had very strong absorption in the 
low UV region and the patterns were similar to the untreated group. Peak 1 level off 
from 275 to 400 nm (figure 20b). Peak 2 had A^^ at 290 and 350 nm with a new A^^ ^ 
introduced at 250 nm. T^  of peak 3 and 4 corresponded to the T^  of astaxanthin-1 and 
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astaxanthin-2. However, no carotenoids absorption characteristics could be detected for 
all four peaks in spite ofhigh magnification (figure 20c). 
Lutein, 1 mgy^g supplement (figure 21): In lutein-fed group, the T^  o f the 450 
nm peak were 1.4, 1.7, 5.9 and 11.2 minutes (Figure 21a). Peak 1 and 2 had high 
absorbance below 350 nm and no absorption characteristics of carotenoids. Peak 1 had 
an A^^ at 275 nm. The shape of spectrum in peak 2 was similar to that in oil-fed group 
except the absence of A^^^ at 250 nm. Peak 3 and 4 showed only barely detectable 
absorbance between 400 and 550 nm (figure 21c). The T^  of the fourth peak matched 
with the standard of lutein, however, one could not identify the presence of carotenoid 
according to the spectrum. 
Lutein, 10 mgy^g supplement (figure 22): When 10 mg/kg lutein was fed to 
the rats, 4 peaks were found in the 450 nm chromatogram (figure 22a and 22b). T^  were 
1.57, 1.96，2.55 and 10.75 minutes respectively. Peak 1, 2 and 3 had an A^^ at 432 nm 
(figure 22c, d). T^  of lutein and peak 4 were the same. However, the absorption was so 
weak that carotenoids could not be identified by the spectral analysis. 
Astaxanthin, 1 mgy^g supplement (figure 23): At a low dose (1 mg>^g) of 
astaxanthin, the chromatogram of the serum (figure 23a) had four peaks detected at 450 
nm. Tr of the 4 peaks were 1.4, 1.7, 9.2 and 11.8 minutes respectively. Peak 1 and 2 had 
high absorption below 300 nm and negligible absorption in the visible absorption band 
(figure 23c). The spectrum of peak 2 was similar to the one of oil-fed group. Spectra of 
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peak 3 and 4 were shown to have a very low carotenoid absorbance under very high 
magnification (figure 23d). They matched with the T^  of astaxanthin-1 and astaxanthin-
2. 
Astaxanthin, 10 mg/kg supplement (figure 24): The chromatogram of the 
serum in a high dose (10 mg/kg) of astaxanthin showed 4 peaks at 450 nm (figure 24a). 
There was a marked rise in peak 1 and 2. T^  of the peaks in this group were 1.57, 1.95, 
2.47 and 10.66 minutes. The spectra of peak 1 and 2 appeared as a board peak at 432 nm 
(figure 24d) like astaxanthin. However, their T^  were quite different from astaxanthin. 
These peaks with A^^ at 432 nm were present only in the group fed with 10 mg/kg 
carotenoids. Although T^  of peak 4 matched with the standard lutein, the absorbance 
was too low that it could not be identified by its spectrum as carotenoid. 
(c) Retina 
Normal diet (figure 25): The retina of normal untreated rats had two peaks 
when the chromatogram was processed at 450 nm (figure 25a). The T^  were 1.4 and 1.5 
minutes respectively. Peak 1 had A^^ x at 210, 260 and 280 nm. Peak 2 had Amax at 210, 
280 and 350 nm. Both of them consisted of mixtures of undefined absorption spectrum 
(figure 25b). No carotenoid was detected when the spectrum was highly magnified 
(figure 25c). 
Oil supplement (figure 26): When olive oil was fed to the rats, the 450 nm 
chromatogram of the extracted retina revealed four peaks (figure 26a). Their T^  were 
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1.45, 1.7，1.93 and 9.89 minutes. Peak 1 had a very strong UV absorption with several 
A^3^ at 210, 275 and 320 nm (figure 26b). Peak 2 had A^^^ at 210, 275 and 350 nm. 
Peak 3 had A^ ^^ ^ at 210, 280 and 384 nm. The strong absorbance of peak 1 to 3 override 
the absorption from 400 to 470 nm. Although T^  of peak 4 closed to that of lutein, the 
spectrum had very little absorption between 400 to 550 nm (figure 26c). 
Lutein, 1 mg/kg supplement (figure 27): Five small peaks were recorded in the 
450 nm of lutein-fed retina (figure 27a) with T^  1.42, 1.67, 1.89, 7.1 and 7.7 minutes. 
All spectra of each peak had several A^^ at the UV absorption band (Figure 27b). Peak 
1 and 2 had maximum absorption below 300 nm with no absorbance characteristic of 
carotenoids (figure 216). Peak 1 had one A^^ x at 210 nm. Peak 2 had A^^^ at 210, 240, 
280 and 350 nm. Peak 3 had the same A^^ as in oil-fed group. Peak 4 and 5 had 
absorption between 400 and 550 nm region. However, their T^  did not match with any of 
our standard carotenoids. 
Lutein, 10 mg/kg supplement (figure 28): Four peaks were recorded in the 
chromatogram of lutein-fed group (figure 28a). Their T^  were 1.45, 1.66, 1.92 and 6.48 
minutes. Peak 1 had high absorption below 300 nm with a shoulder at 323 nm. Peak 2 
had A^3^ at 210, 270 and 350 nm(figure 28b). Peak 3 had A^,^ at 256 and 384 nm. The 
absorbance in peak 4 was so low that carotenoids could not be confirmed by its 
spectrum (figure 28c). 
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Astaxanthin, 1 mg/kg supplement (figure 29): Four peaks were shown in the 
chromatogram of retina in the astaxanthin-fed group (figure 29a). The T^  of the peaks 
were 1.43, 1.69, 1.92 and 9.79 respectively. The absorbance of peak 1 to 3 were nearly 
the same as the tissue fed with lOmg/kg lutein. Peak 4 had absorbance between 450 and 
550 nm only in highly magnified spectrum. The absorption was so low that its identity 
to astaxanthin is questionable. 
Astaxanthin, 10 mg/kg supplement (figure 30): When lOmg/kg astaxanthin 
was fed to the rats, three peaks with T^  1.4，1.7 and 1.9 minutes were seen in the 
chromatogram of the retina (figure 30a). The A^^ ^ of peak 1 located at 323 nm. Peak 2 
had A^^ at 350 nm while Peak 3 had A a^x at 266 and 388 nm. No carotenoid was 
detected. 
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C. Influence of dietary carotenoids on retinol concentration in rats 
1. Serum (Table 7): The concentration of retinol in normal serum of rat varied 
between 200 and 346 ng/ml (SD = 73 ng/ml, n=5). When the rats were fed with oil 
alone, the concentration of the retinol increased significantly (601 士 165 ng/ml, n= l l , 
P<0.0001). However, the administration of lutein or astaxanthin (30 mg/kg) to rats did 
not increase the retinol concentration further. 
2. Retina (Table 8): The variations of retinol in the retina were large. Oil 
administration to rats did not affect retinol in the retina significantly. Feeding 
astaxanthin (10 mg/kg) reduced the retinol in the retina (P<0.05). However, high dosage 
of lutein, 30 mg/kg, increased retinol concentration in the retina (P=0.0014) comparing 
to the oil-fed group. 
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IV. DISCUSSION 
A. Chromatographic analysis of carotenoids and retinoids. 
Retinoids and carotenoids include a large family of structurally related 
compounds. They share a very similar hydrocarbon backbone with conjugated double 
bonds. They differ from each other in the size of the carbon chain and the number as 
well as the position of oxygen functional groups. The oxygen functional group is the 
major determinant of their polarity. The present results demonstrate the feasibility of 
separating these compounds according to their polarity. The nonpolar carotenes have 
low Tr. The oxygen functional groups of lutein, zeaxanthin and astaxanthin increase 
their T .^ The resolution of these compounds by HPLC is dependent on their polarity and 
the polarity of the mobile phase. Variation in the concentration of dioxane and hexane 
are used to adjust the polarity of the mobile phase. After a series of investigation on the 
Tr of different standards using a gradient elution or isocratic elution, an isocratic elution 
by 16% dioxane in hexane was selected for routine analysis. 
Gradient elution has the flexibility in separating multiple compounds in one 
single chromatogram. The resolution is dependent on the slope of the gradient. The 
reproducibility is dependent on the stability of the solvent mixing system. Instrumental 
error in the solvent delivery system often contribute to analytical error. It is much easier 
to control the isocratic elution than a gradient elution. In this study, the gradient elution 
was used to select the optimal concentration of dioxane for isocratic elution. 
The present data showed that an isocratic elution by 16% dioxane is the optimal 
condition for the analysis of retinol, B-carotene, lutein, and astaxanthin in rat serum and 
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tissues. This method enables the separation of retinol, retinoic acid, retinol acetate and 
retinal. However, only retinol can be identified when lipid extracts of serum, subretinal 
fluid, retina or liver were analyzed. The other retinoids cannot be resolved with other 
unidentified lipids. Therefore, among retinoids only retinol is considered in this study. 
The present method provides a fairly good separation of all carotenoids 
concerned in this study. The limitation is the separation of lycopene and B-carotene. 
Fortunately, lycopene is not present in rat serum and tissues, nor in human subretinal 
fluid and retina. Lycopene and B-carotene can be separated by reducing dioxane 
concentration to 1 %. In situation where separation of B-carotene and lycopene was 
necessary, a gradient elution beginning with increasing dioxane from 0-20 % in 10 
minute should be used. 
B. Carotenoid study in human and rats 
1. Carotenoids in human tissues 
(a) Serum: The chromatographic system selected for our study produced data 
consistent with current knowledge of carotenoids. Table 9 showed that p-carotene is the 
major carotenoid in the human serum. However, lycopene is not detected in the serum 
in our normal subjects. Giuliano et al (1992) reported the rapid degradation of lycopene 
during the specimen preparation procedure. Alternatively, lack of intake of lycopene in 
Asian diet is another possible reason for the absence of lycopene in the serum. 
Lycopene is found mainly in tomato products. Dietary intake of Asian do not contain a 
high amount of tomato product on a regular basis. If the diet is lack of tomato product, 
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lycopene may not be detectable in the blood. Others (Krinsky, 1990; Handelman, 
1991) reported that the ratio of zeaxanthin to lutein in the blood is about 10 to 25 %. 
The concentration of zeaxanthin in our sample was about 10 % of lutein. Retinol 
concentration of normal human is also similar to published values (Bowen et al 1993; 
Stacewicz-sapunntzakis, 1993). 
(b) Subretinal fluid: The chromatographic procedure used in this study is a 
simple and sensitive method to analyse retinol and carotenoids concentrations in the 
subretinal fluid. Since the amount of B-carotene and lycopene are very small in the 
subretinal fluid, the isocratic elution with 16% dioxane is adequate for the present study. 
A gradient of increasing dioxane from 0 to 20% has been used to demonstrate the 
separation of B-carotene and lycopene. No lycopene was observed in the subretinal fluid 
(the negative result is not shown). 
The high concentration of lutein in subretinal fluids confirmed previous 
observation that lutein is the major carotenoids in human retina (Bone, 1985; 
Handelman, 1988). It is difficult to obtain the subretinal fluid without a small amount of 
blood contamination. Assuming that there is no B-carotene in the subretinal fluid, the 
small amount (<4%) of B-carotene and cryptoxanthin in subretinal fluid can be used to 
estimate the maximal blood contamination. Since the amounts of retinol, lutein and 
zeaxanthin in the subretinal fluid are 32 %, 26 % and 22 % of those in the serum 
respectively, we conclude that the occurrence of retinol, lutein and zeaxanthin are not 
resulting from blood contamination during sampling of specimens. The marked 
differences between the chromatograms of serum and subretinal fluid indicate the origin 
of these compounds from the degenerating retina rather than from the blood. 
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Bone (1993) proposed the conversion of meso zeaxanthin, a non-dietary 
carotenoid, from lutein in the retina. Their data indicate that zeaxanthin is derived from 
lutein in the retina. On the other hand, most of our patients suffering from mid-
peripheral or peripheral retinal detachment. Lutein is the major carotenoids found in the 
mid-peripheral retina while zeaxanthin has the highest concentration in the macula 
region (Handelman, 1988; Bone, 1997). When the mid-peripheral retina detached, a 
relatively large amount of lutein would be released from the detached retina. 
Both retinol and carotenoids are highly insoluble in an aqueous medium. Their 
occurrence in the subretinal fluid must be maintained in suspension by binding to 
proteins. The occurrence of retinol binding protein in the subretinal fluid has been 
reported by Bridges et al (1986). It is likely that carotenoids in subretinal fluid are also 
bound to proteins. 
The present data show that considerable amounts of retinol and carotenoids are 
present in the subretinal space. If retinol and carotenoids are lost from the retina 
following retinal detachment, the re-attached retina is deficient in these important 
nutrients. The amount of these compounds remaining in the retina, and the ability to 
replenish them could be important factors affecting the surgical outcome. 
2. Dietary supplement of carotenoids to rats 
(a) Choice of animal and types of carotenoids: Photic injury to rat's retina has 
been studied extensively in our laboratory and by others (Penn, 1987; Lee et al 1990; 
Penn and Anderson, 1991). The protective effect of carotenoids in Lewis rats has been 
reported (Lam 1996). Therefore rat is chosen for the present study. 
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Oil was administered to the animals as a vehicle because of the hydrophobic 
properties of carotenoids. Olive oil had been shown to increase the bioavailiability of 
the carotenoids during absorption (Erdman et al, 1993; Solomons et al, 1993). We 
observed the appearance of peak 1 in the 450 nm chromatogram after feeding oil. The 
multiple peaks may be originating from the metabolic products ofoil . 
Lutein is one of the major carotenoids in the human retina. We have 
demonstrated that a considerable amount of lutein was present in the human subretinal 
fluid. If one attempt to apply the animal model to study human diseases, lutein would 
be a good choice. Thus we fed the rats with lutein as one part of this study. 
Astaxanthin was selected in parallel with lutein feeding. In vitro study 
demonstrated the greatest antioxidant effect of astaxanthin among carotenoids (Miki, 
1991). Moreover, protective effect against photic injury by astaxanthin had been 
reported in the rat model (Lam & Tso，1996). Consequently, assessment of these two 
pigments has potential application for human retinal diseases. These two pigments are 
now available for poultry use. They are commercially accessible. 
(b) Carotenoids uptake into rats' tissues: The chromatographic method was 
used to analyze carotenoids in liver, serum and retina of rats after feeding oil, with or 
without carotenoid supplement. The possible occurrence of carotenoids was examined 
first in the 450nm chromatogram. Each peak was re-examined by its spectral 
characteristic. Although many peaks were observed at 450nm, most of them do not have 
the spectral characteristic of carotenoids. When a high amount of lutein (30mg/Kg) was 
fed to rats, a small amount of carotenoid was noticeable in T^  of lutein in the 450 nm 
chromatogram of the liver extract (figure 15a, peak 4 and 5). Its concentration was 
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sufficient to show absorption spectrum of carotenoids (figure 15c). Only barely 
detectable lutein was found in the liver extract when 1 or 10 mg/kg of lutein was fed. 
The amount of carotenoid in the astaxanthin fed group was too low to be confirmed by 
the absorption spectrum (see figure 16-18). When the serum (figure 21-24) and retina 
(figure 27-30) were analysed, lutein and astaxanthin could not be confirmed by their 
absorption spectrum in the 450 nm chromatogram. 
Carotenoids are believed to have protective effect against free radicals damage. 
The absence of carotenoid in rat's model explains their susceptibility to photic injury. 
Other have demonstrated the protective effect against photic injury by oral 
administration of lutein and astaxanthin to rats. These carotenoids must be very potent 
since the present data showed that only a trace amount of orally administrated 
carotenoid entered rat's tissue. 
Although feeding lutein or astaxanthin did show the appearance of the respective 
carotenoid in some specimen of the blood or tissues, the concentration was in the lowest 
limit of our analytical method. This concentration was <1% of the values observed in 
human serum. 
Because of the hydrophobicity of carotenoids, a carrier protein is required to 
keep them in the blood circulation, and transport into the retina. Carotenoid binding 
protein in the human retina has been reported recently by others (Bemstein et al 1997; 
Crabtree, 1997). No study has been reported on the carotenoids binding protein in 
serum. The extremely low concentration of carotenoids in the rats serum after an 
excessive dosage of carotenoid could be resulting from the absence of the carrier protein 
for carotenoid in rats. 
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(c) Effect of dietary carotenoids on retinol concentration in rat tissues: 
Supplementation of oil significantly increased the concentration of retinol in the serum. 
Addition of carotenoid in oil did not raise the retinol concentration further. Thus, the 
change in retinol was affected by the oil rather than carotenoids. In our preliminary 
study, retinol or carotenoids was not found in the olive oil. Therefore, retinol is not 
originating from oil. It is possible that oil promotes the absorption of dietary retinol. 
In the retina, the influence to retinol was different from that of serum. Oil or 
astaxanthin (10 mg/kg) reduced retinol while lutein markedly elevated the concentration 
of retinol in the retina. Vitamin A had been proposed to have antioxidant effect against 
lipid peroxidation (Livrea and Packer 1994). High dosage of lutein may have preserved 
vitamin A in the retina. 
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V. CONCLUSION 
Elution of retinoids and carotenoids from a silica column by 16% dioxane in 
1 
hexane has been shown to be quite suitable for the present study of retinol and 
carotenoids in human and rat tissues. 
Studies on the carotenoids in human serum and subretinal fluid confirmed the 
specificity of lutein as the major carotenoid in human retina. Although abundant 
amounts of several carotenoids are present in human serum, only a considerable amount 
of lutein is present in the subretinal fluid. The data support the previous observation of 
lutein as the major carotenoid in the retina (Bone 1985, 1988，1997). Although 
zeaxanthin is the major carotenoid in the macular, the net amount of zeaxanthin is too 
small to appear as a major carotenoid in the subretinal fluid. The presence of retinol and 
lutein in the subretinal fluid indicates their possible clinical significance as markers to 
estimate the extent of tissue damage after retinal detachment. 
Carotenoids are believed to have protective effect against free radical damage. 
The absence of carotenoids in rat's retina explains their susceptibility to light damage. 
Others have demonstrated the protective effect of astaxanthin and lutein against photic 
injury to rat's retina. The potency of the carotenoid must be very high because only a 
trace amount of carotenoid was observed in some rats after a high dosage of lutein or 
astaxanthin was fed to them. 
There is a possibility that the mega dose of orally administrated carotenoids can 
spare the catabolic reactions of retinol, other physiological antioxidants, or reduce the 
free radical level in the blood circulation. Oral administration of a high dose of lutein 
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did increase retinol concentration in the retina but not in the serum. Future 
investigations should be directed to the influence of carotenoids on the concentration of 
other physiological antioxidants such as ascorbic acid, vitamin E，glutathione as well as 
the concentration of free radicals in the blood circulation. 
This study illustrates a very important difference in carotenoid metabolism 
between rats and human. Human serum contains multiple carotenoids in amount easily 
detectable. Normal rats do not have detectable amount of carotenoids. In spite of orally 
administration of a high dose of carotenoid, only a trace amount was observed in the 
serum and tissues in rats. 
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Table 1. 
The retention time (min) of different carotenoids in several gradient elution conditions 
using the long column. 
n Gradient 1 n Gradient 2 n Gradient 3 
p-carotene 5 1.86土0.10 1 2.45 2 1.43±0.01 
Lycopene 4 2.25±0.21 1 3.63 3 1.55±0.01 
Lutein 4 10.60±0.10 1 14.83 2 7.96士0.03 
Zeaxanthin 1 10.91 - - - -
Gradient 1 : 0% + 2 0 % dioxane in the first five minutes after injection. 
Gradient 2 : 0% + 1 6 % dioxane in the first five minutes after injection. 
Gradient 3 : 5% ">25 % dioxane in the first five minutes after injection. 
47 
Table 2. 
The retention time (min) of different carotenoids in several isocratic conditions using 
the short silica column. 
15% dioxane, 25% dioxane, 30% dioxane, 
n lml/min n lml/min n lml/min 
P-carotene 1 1.44 10 1.39±0.01 - -
Astaxanthin-1 2 10.02i0.02 9 3.73士0.24 4 3.23=t0.15 
Astaxanthin-2 1 12.97 - cannot separate 2 3.87±0.14 
Lutein 4 13.25i0.27 7 4.17±0.12 1 5.73 
Zeaxanthin 2 14.16±0.08 1 4.54 - -
48 
Table 3. 
The retention time (min) of different carotenoids in several isocratic conditions using 
the long column. 
16% dioxane, 25% dioxane, 
n 2ml/min n lml/min 
p-carotene 7 1.35士0.02 - -
Lycopene 1 1.38 - -
Cryptoxanthin 2 3.32±0.01 - -
Astaxanthin-1 2 9.83 ± 0.72 1 8.21 
Astaxanthin-2 1 12.02 1 9.25 
Lutein 3 10.76±0.17 1 8.57 
Zeaxanthin 5 11.56±0.85 - -
49 
Table 4. 
Retention time (min) and absorption maximum (nm) of retinoid and carotenoids 
standard in the selected procedure. (See figure 1 to 7) 
Tr (minute) A a^x (nm) 
Retinol acetate 1.6 327 
All trans retinal 1.9 370 
All trans retinoic 2.6 350 
All trans retinol 3.1 327 
B-carotene 1.3 425,451,480 
Lycopene 1.4 448,471,500 
Cryptoxanthin 3.3 425,451,480 ‘ 
Astaxanthin-1 9.8 475 
Lutein 10.7 422,446,475 
Zeaxanthin 11.5 427，453，481 
Astaxanthin-2 12.0 369,468 
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Table 5. 
The concentration (mean 士 SD) of carotenoids in normal human serum 
ng/ml nmol/ml 
n Mean±SD M e a n ± S D 
P-carotene 13 259±1：33 0.48士0.25 
Cryptoxanthin 13 209± 105 0.37±0.19 
Lutein 13 176±60 0.31 ±0.11 
Zeaxanthin 13 4 ± 2 0.01 ± 0.00 
Retinol 13 718±24 2.51±0.83 
I 1 I 
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Table 6. 
The concentrations (mean ±SD) of retinol and carotenoids in patients' serum and 
subretinal fluid 
n Serum, Subretinal fluid, SRF/serum ratio 
ng/ml ng/ml % 
B-carotene 6 206±47 5土 2 2.5% 
Cryptoxanthin 6 180± 86 5士2 2.8% 
Lutein 6 147±34 3 9 ± 2 5 26% 
Zeaxanthin 6 9 ± 3 2 ± 3 22% 
Retinol 6 668± 155 215± 120 32% 
52 
Table 7. 
The concentration of retinol in the serum of rats. 
Group Description retinol per ml serum 
No. n (ng/ml) 
Group 1 Normal diet 5 273 ± 73 
Group 2 Oil supplement 11 601 士 165 
Group 3 Lutein (30mg/kg) supplement 4 432 土 82 
Group 4 Astaxanthin (30mg/kg) supplement 14 505 士 160 
T-test 
Group P value 
1 Vs 2 0.0001 
1 Vs 3 0.0225 
1 Vs 4 0.0006 
2 Vs 3 0.0242 
2 V s 4 0.1572 
3 Vs 4 0.2496 
53 
Table 8. 
The concentration of retinol in the retina of rats. 
Description weight of retinol weight of retinol 
(ng) per retina per gram retina 
n Mean 士 SD (^g/g)Mean 士 SD 
Group 1 Normal diet 10 101.1士52.0 7.3士2.7 
Group 2 + olive oil 34 89.9 ± 49.3 5 .2±3.5 
Group 3 +astaxanthin (lOmg/kg) 30 75.6士27.8 4 .5±2.0 
Group 4 +lutein (30mgy^g) 12 136.4士36.0 10.8士4.6 
Statistical test 
Unpaired t-test 
Group P value P value 
(comparing wt of retinol ) ( comparing wt of retinol per gram retina) 
1 V s 2 0.55580 0.06501 
1 V s 3 0.16713 0.01221 
l V s 4 0.08873 0.03809 
2 V s 3 0.15182 0.33412 
2 V s 4 0.00181 0.00143 
3 Vs 4 0.0000708 0.00054 
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Table 9. 
The concentrations of carotenoids and retinoids in human serum 
N=48, women, N=11 (4 man 7 N=160, Caucasians, 
*1 women), *2 *3 
P-carotene 207± 124 462士318 190±136 
a-carotene 52 士 57 165 士 110 48 土 37 
Cryptoxanthin 136士 85 - 9 5 ± 7 2 
(P-cryptoxanthin) 
Lycopene 254士 176 481士 193 293 士 163 
Lutein 196±69 - 115士58 
Retinol 434士 107 - 643±175 
Retinyl palmitate - - 73 士 143 
Zeaxanthin - - 3 0 ± 1 7 
Mean 士 SD in ng/ml 
*1. P.E. Bowen 1993 (origin value converted from ^ig/dL ). 
*2. A. Carughi 1993. 
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Figure 12b. Absorption spectra of the peaks showed 
in figure 12a. 
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Figure 13a. Chromatogram of liver from rats fed 
with oil at 450 nm. 
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Figure 13b. Absorption spectra ofthe peaks showed 
in figure 13a. 
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Figure 13c. Higher magnified (x 300) spectra of the 
peaks showed in figure 13b. 
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Figure 13d. Further magnified (x 750) spectra of the 
peaks showed in figure 13b. 
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Figure 14a. Chromatogram of liver from rat fed 
with lutein (lmg/kg) at 450 nm. 
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Figure 29b. Absorption spectra of the peaks showed 
in figure 29a. 
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Figure 14c. Highly magnified (x 80) spectra of the 
peaks showed in figure 14b. 
0 . 0 0 2 0 p ~ | n ； ^ ^ ~ ~ ~ \ I 
3 5 \ f ] ! l \2 
I B � “ I 3 I \ 
0.0015 t 1 \ i ! 1^ \ \3 
� ] VJ、 \ \ . 
c ！ 1 A V I \ \ 
E 0 . 0 0 1 0 [ i � \ \ t \ . \ f V \ V , \ 
o i ^ ' I / v \ 4 \ %；\\1 \ 
l o . o o o s l 1 / . } v | l \ —i， :_fMkkJi 
200 300 400 500 600 
wavelength (nm) 
Figure 14d. Further magnified (x 800) spectra of the 
peaks showed in figure 14b. 
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Figure 15a. Chromatogram of liver from rat fed 
with lutein (30mg/kg) at 450 nm. 
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Figure 15b. Absorption spectra of the peaks showed 
in figure 15a. 
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Figure 15c. Highly magnified (x 180) absorption 
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Figure 16a. Chromatogram of liver from rat fed with 
astaxanthin (lmg/kg) at 450 nm • 
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Figure 16b. Absorption spectra of the peaks showed 
in figure 16a. 
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Figure 17a. Chromatogram of liver from rat fed with 
astaxanthin (lOmg/kg) at 450 nm. 
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Figure 29b. Absorption spectra of the peaks showed 
in figure 29a. 
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Figure 17c. Highly magnified (x 150) absorption 
spectra of the peaks showed in figure 17b. 
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Figure 18a. Chromatogram of liver from rat fed with 
astaxanthin (30mg/kg) at 450 nm • 
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Figure 29b. Absorption spectra of the peaks showed 
in figure 29a. 
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Figure 18c. Higher magnified (x 625) absorption 
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Figure 19a. Chromatogram of serum from rats fed 
with normal diet at 450 nm . 
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Figure 19b. Absorption spectra of the peaks showed 
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Figure 19c. Highly magnified (x 20) absorption 
spectra ofthe peaks showed in figure 19b. 
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Figure 20a. Chromatogram ofserum from rats fed 
with oil at 450 nm. 
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Figure 20b. Absorption spectra of the peaks showed 
in figure 20a. 
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Figure 20c. Highly magnified (x 100) absorption 
spectra of the peaks showed in figure 20b. 
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Figure 21a. Chromatogram of serum from rats fed 
with lutein (lmg/kg) at 450 nm. 
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Figure 21b. Absorption spectra of the peaks showed 
in figure 21a. 
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Figure 21c. Highly magnified (x 800) absorption 
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Figure 22a. Chromatogram of serum from rat fed 
with lutein (lOmg/kg) at 450 nm. 
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Figure 22b. Highly magnified (x 40) chromatogram 
ofthe absorption peaks showed in figure 22a. 
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Figure 22c. Absorption spectra of the peaks showed 
in figure 22b. 
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Figure 22d. Highly magnified (x 30) absorption 
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Figure 23a. Chromatogram of serum from rats fed 
with astaxanthin (lmg/kg) at 450 nm. 
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Figure 23b. Absorption spectra of the peaks showed 
in figure 23b. 
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Figure 23c. Highly magnified (x 500) absorption 
spectra of the peaks showed in figure 23b. 
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Figure 24a. Chromatogram ofserum from rats fed 
with astaxanthin (lOmg/kg) at 450 nm. 
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Figure 24b. Highly magnified chromatogram (x 25) 
of the absorption peaks showed in figure 24a 
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Figure 24c. Absorption spectra ofthe peaks showed 
in figure 24b. 
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Figure 24d. Highly magnified (x 25) absorption 
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Figure 25a. Chromatogram of retina from rat fed with 
normal diet at 450 nm. 
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Figure 29b. Absorption spectra of the peaks showed 
in figure 29a. 
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Figure 25c. Highly magnified (x 20) absorption 
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Figure 26a. Chromatogram of retina from rat fed 
with oil at 450 nm. 
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Figure 29b. Absorption spectra of the peaks showed 
in figure 29a. 
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Figure 26c. Highly magnified (x 16) absorption spectra 
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Figure 27a. Chromatogram of retina from rat fed with 
lutein (lmg/kg) at 450 nm. 
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Figure lOb. Absorption spectra of the peaks showed 
in figure lOa. 
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Figure 27c. Highly magnified (x 17) absorption 
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Figure 28a. Chromatogram of retina from rats fed 
with lutein (lOmg/kg) at 450 nm. 
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Figure 29b. Absorption spectra of the peaks showed 
in figure 29a. 
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Figure 28c. Highly magnified (x 18) absorption 
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Figure 29a.Chromatogram of retina from rats fed 
with astaxanthin (lmg/kg) at 450 nm. 
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Figure 29b. Absorption spectra of the peaks showed 
in figure 29a. 
102 
\ 
0 . 0 0 1 0 p j i \ ~ ~ n 
3 
0.0008 - I \ 1 \ 
s i . \ \ 2 
< 0.0007- j ^ V, ,\ 
c 0.0005 - I ！ M \、 
I 0.0003 - ！ ; V h \ W v 
姜 蒙 - r ^ ^ 
0 . 0 0 0 0 L ^ " “ ^ ^ — — ‘ — — ‘ — — ‘ 1 ~ 〜 作 \ 
200 300 400 500 600 
wavelength (nm) 
Figure 29c. Highly magnified (x 200) absorption 
spectra of the peaks showed in figure 29b. 
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Figure 30a. Chromatogram of retina from rats fed 
with astaxanthin (lOmg/kg) at 450 nm. 
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Figure 30b. Absorption spectra ofthe peaks showed 
in figure 30a. 
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Figure 30c. Highly magnified (x 10) spectra of the 
peaks showed in figure 30b. 
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